PR Newswire Clinical TrialsOriginal article
Nova Biomedical breidt geïntegreerde workflows voor de ontwikkeling van cellijnen uit: NanoCellect-producten maken nu deel uit van Nova Biomedical
Positive
AI Analysis
Summary
Nova Biomedical announced a transaction to acquire certain assets from NanoCellect, a supplier of microfluidic technology for cell sorting, expanding Nova's integrated cell line development workflows.
Importance:5/10
Sentiment:
0.30
acquisitioncell line developmentmicrofluidic technologyasset purchase
Read the original article
Published by PR Newswire Clinical Trials on July 25, 2026 7:14 PM